Shanghai Haohai Biological Technology Co. Ltd. (6826)

Overview

Shanghai Haohai Biological Technology Co., Ltd., established in 2007 and headquartered in Shanghai, China, stands as a paramount figure in the biomedical materials industry, not only within its domestic borders but also internationally. The company initially known as Haohai Limited until its rebranding in 2010, has carved a niche for itself through its dedication to research, development, manufacture, and sale of a wide range of biomedical products. Engaging in a broad spectrum of sectors, including ophthalmology, medical aesthetics, biological engineering, and pharmaceutical products, Shanghai Haohai Biological Technology Co., Ltd. also extends its expertise to technology transfer and consultation services. This multifaceted approach underscores the company’s commitment to advancing healthcare through innovation.

Products and Services

Shanghai Haohai Biological Technology Co., Ltd.'s portfolio encompasses an extensive array of products and services designed to meet the diverse needs of the medical and healthcare communities:

• Ophthalmology Products: This range includes intraocular lenses for cataract surgery, medical sodium hyaluronate gel for ophthalmic surgery assistance, and lubricant eye drops for dry eye relief.
• Sodium Hyaluronate Injection: Primarily used in joint disorders, these injections serve as a lubricant and shock absorber, providing pain relief and improved mobility.
• Medical Chitosan: This biopolymer has diverse applications, including wound healing and as a biomaterial in tissue engineering.
• Anti-Adhesion and Burn Wound Products: These products are designed to prevent post-surgical adhesions and aid in the healing of burn wounds, enhancing recovery outcomes.
• Medical Aesthetics Products: The company’s foray into medical aesthetics includes Matrifill, a first-generation HA dermal filler for skin volume restoration; Janlane, a second-generation HA dermal filler tailored for dynamic wrinkles; and Hyalumatrix, a third-generation HA dermal filler that specializes in precise facial contouring. Additionally, the company offers genetic-engineering preparations for epidermal repair and devices for aesthetic procedures, such as radio frequency and laser equipment.
• Biological Engineering and Pharmaceutical Products: Engaging in cutting-edge research and development, Shanghai Haohai provides innovative solutions that span biological reagents, biologicals and biological materials. This segment also involves the manufacture and sale of related machinery and accessories.
• Technology Transfer and Consultation Services: Beyond product development and manufacturing, Shanghai Haohai plays a pivotal role in the dissemination of knowledge and technology, facilitating advancements in medical practices through effective consultation and technology transfer services.